The novel, soy-allergen free, non GMO Phosphatidylserine product -Sharp-PS® GREEN by Enzymotec, has received GRAS status from the FDA. This status allows the marketing and
Enzymotec’s High-potency K·REAL® krill oil gains EU Novel Food approval, allowing additional health claims
Enzymotec announced that its high-potency grade of K·Real® krill oil has received Novel Food approval from the European Commission (EC). This approval allows high grades
Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid ingredients, recently announced the appointment of Holger Liepmann to its Board of Directors. Holger
Enzymotec strengthen its global position in the omega 3 market with new granted “Master patents” in USA and Australia for phospholipid based products.
Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it was granted patents by the U.S. Patent and Trademark
Enzymotec Ltd., a leading global supplier of specialty lipid-based products and solutions, is initiating a Human Milk Center to promote research, development and innovation in
Enzymotec Ltd. Granted Patent in Australia for the use of INFAT to promote development of beneficial gut flora and reduce infant crying.
Enzymotec announced today that INFAT®, the innovative ingredient that is marketed by Advanced Lipids, was granted a patent by the Australian Patent and Trademark Office